查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1696281

全球血液加温设备市场 - 2025 至 2033 年

Global Blood Warmer Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球血液加温设备市场规模达到 13.8 亿美元，预计到 2033 年将达到 121.1 亿美元，2025-2033 年预测期内的复合年增长率为 24.2%。

血液加温装置是一种医疗设备，可在给患者输注血液和静脉液之前提高其温度，防止在手术、创伤护理或大量输血期间出现体温过低的情况。它们确保液体与患者的体温相匹配，从而减少心律不整和凝血病等併发症。它们广泛应用于医院、紧急医疗服务、军事环境和重症监护室，以提高患者安全性并改善临床结果。

市场动态：

驱动因素与约束因素

低温症盛行率不断上升

全球血液加温设备市场正在不断增长，因为体温过低的盛行率日益增加，体温过低是外科手术、创伤病例和紧急医疗情况下的常见风险。医疗机构越来越多地采用血液加温装置，以确保在输液和输血过程中安全有效地调节温度。人们对体温过低相关风险的认识不断提高，以及血液加温技术的进步，正在推动市场需求，使得这些设备成为现代医疗保健中必不可少的设备。

例如，根据 NCBI 2024 年的研究，在美国，每年发生 700-1500 起与体温过低有关的死亡事件，主要影响 30-49 岁的成年人，男性的发生率高出 10 倍。儘管住院护理得到优化，中度至重度低温症的死亡率仍接近 50%。

先进血液加温装置成本高昂

先进的血液加温设备成本高昂，特别是在中低收入国家，阻碍了市场的成长。这些设备需要大量投资，小型医疗机构和紧急服务机构不容易获得。维护、一次性配件和法规遵循的成本增加了医疗保健提供者的财务负担。这种可负担性障碍限制了其广泛采用，特别是在医疗资金不足的地区。为了克服这个问题，需要采取降低价格、政府支持和具有成本效益的解决方案等策略性努力，以提高可近性并改善全球患者护理。

例如，血液加温器是输血前加热血液和静脉液、防止体温过低和提高病人安全性的重要医疗工具。印度的价格根据品牌、功能和技术而有所不同，从基本型号的 250 美元到高级系统的 2,000 美元不等。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 技术片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 低温症盛行率不断上升
      • 便携式和电池供电血液加温器技术的进步
    • 限制
      • 先进血液加温装置成本高昂
      • 严格的监管批准和合规要求
    • 机会
      • 物联网和基于人工智慧的监控系统集成，实现精确温度控制
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有销售量最大的品牌的既定领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：依产品类型

  • 手提式血液加温器
  • 非携带式血液加温器

第 6 章：按技术

  • 干热板加热器
  • 水浴加热器
  • 红外线暖器

第 7 章：按最终用户

  • 医院和诊所
  • 门诊手术中心
  • 紧急医疗服务

第 8 章：区域市场分析与成长机会

  • 北美洲
    • 各区域关键动态
      • 我们
      • 加拿大
  • 欧洲
    • 各区域关键动态
      • 德国
      • 英国
      • 法国
      • 西班牙
      • 义大利
      • 欧洲其他地区
  • 拉丁美洲
    • 各区域关键动态
      • 墨西哥
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地区
  • 亚太
    • 各区域关键动态
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 各区域关键动态

第九章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第十章：公司简介

  • 3M
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Stryker Corporation
  • ICU Medical
  • Baxter International Inc
  • GE Healthcare
  • Belmont Medical Technologies
  • IndexIndes
  • Keewell Medical Technology Co., Ltd
  • Narang Medical Limited
  • Biegler GmbH

第 11 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 12 章：附录

简介目录
Product Code: MD9383

The global blood warmer devices market reached US$ 1.38 billion in 2024 and is expected to reach US$ 12.11 billion by 2033, growing at a CAGR of 24.2% during the forecast period 2025-2033.

Blood warmer devices are medical equipment that raise the temperature of blood and intravenous fluids before administration to patients, preventing hypothermia during surgeries, trauma care, or massive blood transfusions. They ensure fluids match the patient's body temperature, reducing complications like cardiac arrhythmias and coagulopathy. They are widely used in hospitals, emergency medical services, military settings, and critical care units to enhance patient safety and improve clinical outcomes.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Hypothermia

The global blood warmer devices market is growing due to the increasing prevalence of hypothermia, a common risk in surgical procedures, trauma cases, and emergency medical situations. Healthcare facilities are increasingly adopting blood warmer devices to ensure safe and effective temperature regulation during fluid and blood transfusions. The growing awareness of hypothermia-related risks and advancements in blood-warming technology are driving market demand, making these devices essential in modern medical care.

For instance, according to NCBI studies 2024, in the US, 700- 1500 hypothermia-related fatalities occur annually, primarily affecting adults aged 30-49, with men experiencing a 10 times higher incidence. Despite optimized in-hospital care, the mortality rate of moderate to severe hypothermia approaches 50%.

High Cost of Advanced Blood Warmer Devices

The high cost of advanced blood warmer devices, particularly in low- and middle-income countries, hinders market growth. These devices require substantial investment and are less accessible to smaller healthcare facilities and emergency services. The cost of maintenance, disposable accessories, and regulatory compliance adds to the financial burden on healthcare providers. This affordability barrier restricts widespread adoption, especially in regions with inadequate healthcare funding. To overcome this, strategic efforts like price reductions, government support, and cost-effective solutions are needed to enhance accessibility and improve patient care worldwide.

For instance, blood warmer devices are crucial medical tools used to heat blood and intravenous fluids before transfusions, preventing hypothermia and enhancing patient safety. Prices in India vary based on brand, features, and technology, ranging from USD 250 for basic models to USD 2,000 for advanced systems.

Segment Analysis

The global blood warmer devices market is segmented based on product type, technology, end-user and region.

Product Type:

The portable blood warmers from the product type segment are expected to dominate the blood warmer devices market with the highest market share

Portable blood warmers are lightweight medical devices used to heat blood and intravenous fluids before administration, especially in emergency and field settings. They are commonly used in ambulances, military operations, and pre-hospital care to prevent hypothermia in trauma patients. Operating on battery power or external power sources, they are ideal for remote locations and critical care transport.

The portable blood warmer market is driven by the growing demand for emergency medical services and military healthcare, particularly in cases of trauma, accidents, and battlefield injuries. Advancements in battery-operated, lightweight technologies have made them more accessible for field applications. The adoption of air and ground ambulances, stringent healthcare regulations, and expanding healthcare infrastructure in remote and rural areas are also driving market growth.

For instance, in June 2024, Danish MedTech company, MEQU, has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its portable blood & IV fluid warmer system, the °M Warmer System. The FDA clearance marks a significant milestone for the company, marking the end of over a decade of product development. The company is excited to assist U.S. healthcare professionals in saving lives with the M Warmer System.

Geographical Analysis

North America is expected to hold a significant position in the blood warmer devices market with the highest market share

North America dominates the global blood warmer devices market due to its established healthcare infrastructure, rise in product launches, advanced medical technologies, and increasing surgical procedures. The rising prevalence of hypothermia in trauma and surgical patients, along with the increasing number of blood transfusions, drives demand for these devices in hospitals and emergency care settings.

For instance, in June 2023, ICU Medical, Inc., a global leader in medical device development, has introduced the Level 1 H-1200 Fast Flow Fluid Warmer, a vital tool for heating blood, blood products, and intravenous solutions in hospital settings, particularly for patients experiencing blood loss, hypothermia after surgery, or urological irrigation.

Moreover, Key market players, continuous technological advancements, and government initiatives to improve patient safety contribute to market growth. North America also benefits from military and pre-hospital emergency services that require portable, efficient blood-warming solutions.

Competitive Landscape

The major global players in the blood warmer devices market include 3M, Stryker Corporation, ICU Medical, Baxter International Inc., GE Healthcare, Belmont Medical Technologies, Indes, Keewell Medical Technology Co., Ltd, Narang Medical Limited and Biegler GmbH, among others.

Key Developments

  • In August 2024, the Delta Development Team introduced the Single Unit Blood Warmer (SUBW), a revolutionary prehospital blood delivery device that has passed rigorous FDA testing. The device is set to revolutionize blood-warming technology for military operations, rural emergency rooms, and emergency response teams, and is on track for a 510(k) submission.
  • In April 2024, Babson Diagnostics developed a unique hand-warming technology for blood testing, specifically designed for high-quality blood samples from fingertips. The technology, developed in collaboration with biomedical engineering experts, is a step towards addressing the lack of off-the-shelf solutions for blood collection from fingertips. The hand-warming method is a common method used to aid blood collection, but Babson's innovative approach addresses the unique needs of its customers.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global blood warmer devices market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Prevalence of Hypothermia
      • 3.1.1.2. Advancements In Portable and Battery-Operated Blood Warmer Technologies
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Advanced Blood Warmer Devices
      • 3.1.2.2. Stringent Regulatory Approvals and Compliance Requirements
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration of IoT And AI-Based Monitoring Systems for Precise Temperature Control
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with the largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Portable Blood Warmers*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Non-Portable Blood Warmers

6. By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Dry Heat Plate Warmers*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Water Bath Warmers
  • 6.4. Infrared Warmers

7. By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals & Clinics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Emergency Medical Services

8. Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. Latin America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Mexico
      • 8.4.6.2. Brazil
      • 8.4.6.3. Argentina
      • 8.4.6.4. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. 3M*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Stryker Corporation
  • 10.3. ICU Medical
  • 10.4. Baxter International Inc
  • 10.5. GE Healthcare
  • 10.6. Belmont Medical Technologies
  • 10.7. IndexIndes
  • 10.8. Keewell Medical Technology Co., Ltd
  • 10.9. Narang Medical Limited
  • 10.10. Biegler GmbH

LIST NOT EXHAUSTIVE

11. Assumptions and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us